Human NKG2D/CD314 Antibody

Clone 149810 was used by HLDA to establish CD designation
  (57 citations)
(1 Review)
    
Datasheet / CoA / SDS
Product Details
Citations (57)
FAQs
Supplemental Products
Reviews
  • Species Reactivity
    Human
  • Specificity
    Detects human NKG2D/CD314 in Western blots.
  • Source
    Monoclonal Mouse IgG1 Clone # 149810
  • Purification
    Protein A or G purified from hybridoma culture supernatant
  • Immunogen
    BaF3 mouse pro-B cell line transfected with human NKG2D/CD314
  • Formulation
    Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
  • Endotoxin Level
    <0.10 EU per 1 μg of the antibody by the LAL method.
  • Label
    Unconjugated
Product Datasheets

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Certificate of Analysis Lookup

Certificate of Analysis Request Form

To download a Certificate of Analysis, please enter the catalog and lot numbers in the search box below.

Note: Certificate of Analysis not available for kit components.

Applications
  •  
    Recommended
    Concentration
    Sample
  • Western Blot
    1 µg/mL
    Recombinant Human NKG2D/CD314 Fc Chimera (Catalog # 1299-NK)
    under non-reducing conditions only
  • Flow Cytometry
    2.5 µg/106 cells
    Human whole blood CD56+ natural killer cells
  • Costimulation of T Cells
    Rincon-Orozco, B. et al. (2005) J. Immunol. 175:2144.
  • CyTOF-ready
    Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
  • Neutralization
    Kwong, K.Y. et al. (2008) J. Mol. Biol. 384:1143.
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Preparation and Storage
  • Reconstitution
    Reconstitute at 0.5 mg/mL in sterile PBS.
    Reconstitution Buffer Available
  • Shipping
    The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
  • Stability & Storage
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    • 12 months from date of receipt, -20 to -70 °C as supplied.
    • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
    • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: NKG2D/CD314

NKG2D is a type II transmembrane glycoprotein having an extracellular lectin-like domain. This domain lacks the recognizable calcium-binding sites found in true C‑type lectins and binds protein rather than carbohydrate ligands. Human NKG2D is expressed on CD8+ alpha beta T cells, gamma δ T cells, NK cells, and NKT cells. In mouse systems NKG2D also occurs on macrophages. Human ligands for NKG2D include MICA, MICB, and ULBP1, 2, and 3. Expression of NKG2D ligands occurs in epithelial cells, tumor cells and under conditions of stress or infection. NKG2D exists as a disulfide-linked homodimer that delivers an activating signal upon ligand binding. Signaling requires association with an adapter protein. Alternative splicing of the NKG2D mRNA results in isoforms with different cytoplasmic domains that can associate either with DAP12 to deliver a true activating signal or with DAP10 resulting in a costimulatory signal. NKG2D has been implicated in anti-tumor surveillance and the immune response against viral infection.

  • References:
    1. Li, P. et al. (2001) Nature Immunol. 2:443.
    2. Steinle, A. et al. (2001) Immunogenetics 53:279.
    3. Cosman, D. et al. (2001) Immunity 14:123.
    4. Cerwenka, A. and L. Lanier (2001) Immunol. Rev. 181:158.
    5. Wu, J. et al. (1999) Science 285:730.
    6. Diefenbach, A. et al. (2002) Nature Immunol. 3:1142.
    7. Gilfillan, S. et al. (2002) Nature Immunol. 3:1150.
    8. Groh, V. et al. (2001) Nature Immunol. 2:255.
    9. Cerwenka, A. et al. (2001) Proc. Natl. Acad. Sci. USA 98:11521.
    10. Diefenbach, A. et al. (2001) Nature 413:165.
    11. NKG2D and its Ligands (2002) www.RnDSystems.com.
  • Long Name:
    Natural Killer G2D
  • Entrez Gene IDs:
    22914 (Human); 27007 (Mouse)
  • Alternate Names:
    CD314 antigen; CD314; D12S2489E; FLJ17759; FLJ75772; Killer cell lectin-like receptor subfamily K member 1; killer cell lectin-like receptor subfamily K, member 1; KLR; KLRK1; NK cell receptor D; NKG2-D type II integral membrane protein; NKG2D; NKG2-D; NKG2-D-activating NK receptor; NKG2DDNA segment on chromosome 12 (unique) 2489 expressed sequence
Related Research Areas
Citations:

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

57 Citations: Showing 1 - 10
Filter your results:

Species
Applications
Sample Type
  1. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells
    Authors: Z Djaoud, LA Guethlein, A Horowitz, T Azzi, N Nemat-Gorg, D Olive, D Nadal, PJ Norman, C Münz, P Parham
    J. Exp. Med., 2017;0(0):.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  2. Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20
    Authors: Y Charpak-Am, T Kubsch, E Seidel, E Oiknine-Dj, N Cavaletto, R Yamin, D Schmiedel, D Wolf, G Gribaudo, M Messerle, L Cicin-Sain, O Mandelboim
    Sci Rep, 2017;7(1):8661.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  3. Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and ?? T cell-mediated lysis in multiple myeloma
    Authors: C Niu, H Jin, M Li, S Zhu, L Zhou, F Jin, Y Zhou, D Xu, J Xu, L Zhao, S Hao, W Li, J Cui
    Oncotarget, 2017;8(4):5954-5964.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  4. EBI3 regulates the NK cell response to mouse cytomegalovirus infection
    Authors: H Jensen, SY Chen, L Folkersen, GP Nolan, LL Lanier
    Proc. Natl. Acad. Sci. U.S.A, 2017;0(0):.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  5. Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells
    Authors: X Cai, A Caballero-, MM Gewe, IC Jenkins, CW Drescher, RK Strong, T Spies, V Groh
    Neoplasia, 2017;19(6):471-482.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  6. Prognostic significance and functional implication of immune activating receptor NKG2D in gastric cancer
    Authors: F Lin, C Dai, X Ge, W Tang, Y Lin, Y Wang, J Li
    Biochem. Biophys. Res. Commun., 2017;0(0):.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  7. Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
    Authors: JRM Van Audena, J De Waele, E Marcq, J Van Loenho, E Lion, JMJ Van den Be, R Jesenofsky, A Masamune, G Roeyen, P Pauwels, F Lardon, M Peeters, ELJ Smits
    Oncotarget, 2017;0(0):.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  8. SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice
    Authors: M Ke, H Wang, Y Zhou, J Li, Y Liu, M Zhang, J Dou, T Xi, B Shen, C Zhou
    Oncotarget, 2016;7(31):49509-49526.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  9. NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma
    Oncotarget, 2016;0(0):.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  10. A functional polymorphism in the NKG2D gene modulates NK-cell cytotoxicity and is associated with susceptibility to Human Papilloma Virus-related cancers
    Sci Rep, 2016;6(0):39231.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  11. Central nervous system acute lymphoblastic leukemia: role of natural killer cells.
    Authors: Frishman-Levy L, Shemesh A, Bar-Sinai A, Ma C, Ni Z, Frenkel S, Muench V, Bruckmueller H, Vokuhl C, Debatin K, Eckert C, Stanulla M, Schrappe M, Campbell K, Loewenthal R, Schewe D, Hochman J, Meyer L, Kaufman D, Cario G, Porgador A, Izraeli S
    Blood, 2015;125(22):3420-31.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  12. Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.
    Authors: Giannattasio A, Weil S, Kloess S, Ansari N, Stelzer E, Cerwenka A, Steinle A, Koehl U, Koch J
    BMC Cancer, 2015;15(0):351.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  13. Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1.
    Authors: Kruse V, Hamann C, Monecke S, Cyganek L, Elsner L, Hubscher D, Walter L, Streckfuss-Bomeke K, Guan K, Dressel R
    PLoS ONE, 2015;10(5):e0125544.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow
  14. A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function.
    Authors: Karimi M, Aguilar O, Zou B, Bachmann M, Carlyle J, Baldwin C, Kambayashi T
    J Immunol, 2014;193(6):2764-71.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow
  15. L-plastin is involved in NKG2D recruitment into lipid rafts and NKG2D-mediated NK cell migration.
    Authors: Serrano-Pertierra E, Cernuda-Morollon E, Brdicka T, Hooejsi V, Lopez-Larrea C
    J Leukoc Biol, 2014;96(3):437-45.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  16. Natural killer cells induce eosinophil activation and apoptosis.
    Authors: Awad A, Yassine H, Barrier M, Vorng H, Marquillies P, Tsicopoulos A, Duez C
    PLoS ONE, 2014;9(4):e94492.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  17. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.
    Authors: Molfetta R, Quatrini L, Capuano C, Gasparrini F, Zitti B, Zingoni A, Galandrini R, Santoni A, Paolini R
    Eur J Immunol, 2014;44(9):2761-70.
    Species: Human
    Sample Type: Whole Cells
    Application: ICC
  18. Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
    Authors: Sangiolo, Dario, Mesiano, Giulia, Gammaitoni, Loretta, Leuci, Valeria, Todorovic, Maja, Giraudo, Lidia, Cammarata, Cristina, Dell'Aglio, Carmine, D'Ambrosio, Lorenzo, Pisacane, Alberto, Sarotto, Ivana, Miano, Sara, Ferrero, Ivana, Carnevale-Schianca, Fabrizio, Pignochino, Ymera, Sassi, Francesc, Bertotti, Andrea, Piacibello, Wanda, Fagioli, Franca, Aglietta, Massimo, Grignani, Giovanni
    Cancer Res, 2014;74(1):119-29.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  19. Dok1 and Dok2 proteins regulate natural killer cell development and function.
    Authors: Celis-Gutierrez J, Boyron M, Walzer T, Pandolfi P, Jonjic S, Olive D, Dalod M, Vivier E, Nunes J
    EMBO J, 2014;33(17):1928-40.
    Species: Human
    Sample Type: Whole Cells
    Application: Bioassay
  20. Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity.
    Authors: Ham, Hyoungju, Guerrier, Sabrice, Kim, JungJin, Schoon, Renee A, Anderson, Erik L, Hamann, Michael, Lou, Zhenkun, Billadeau, Daniel D
    J Immunol, 2013;190(7):3661-9.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  21. Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRgamma activation.
    Authors: Leung W, Vong Q, Lin W, Janke L, Chen T, Leung W
    J Exp Med, 2013;210(12):2675-92.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  22. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.
    Authors: Lim S, Kim T, Lee J, Sonn C, Kim K, Kim J, Choi J, Choi I, Yun C, Kim J, Yee C, Kumar V, Lee K
    Cancer Res, 2013;73(8):2598-607.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  23. Mechanisms of the antitumor activity of human Vgamma9Vdelta2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.
    Authors: Di Carlo E, Bocca P, Emionite L, Cilli M, Cipollone G, Morandi F, Raffaghello L, Pistoia V, Prigione I
    Mol Ther, 2013;21(5):1034-43.
    Species: Human
    Sample Type: Whole Cells
    Application: Bioassay
  24. A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions.
    Authors: Windheim, Mark, Southcombe, Jennifer, Kremmer, Elisabet, Chaplin, Lucy, Urlaub, Doris, Falk, Christin, Claus, Maren, Mihm, Janine, Braithwaite, Myles, Dennehy, Kevin, Renz, Harald, Sester, Martina, Watzl, Carsten, Burgert, Hans-Ger
    Proc Natl Acad Sci U S A, 2013;110(50):E4884-93.
    Species: Human
    Sample Type: Whole Cells
    Application: Bioassay
  25. The road to memory: an early rest for the long journey.
    Authors: Ho, Liam Poc, Yit, Pui San, Ng, Lee Hui, Linn, Yeh Chin, Zhao, Yi, Sun, Li, Ling, Khoon Li, Chai Koh, Mickey B, Monica Shih, Meng-Chu, Li, Shang, Wang, Xue Ying, Tien, Sim Leng, Goh, Yeow Tee
    J Immunol, 2013;191(11):5603-14.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  26. CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling.
    Authors: Hosomi S, Chen Z, Baker K, Chen L, Huang Y, Olszak T, Zeissig S, Wang J, Mandelboim O, Beauchemin N, Lanier L, Blumberg R
    Eur J Immunol, 2013;43(9):2473-83.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  27. Human TCR gamma delta+ T cells represent a novel target for IL-27 activity.
    Authors: Morandi F, Prigione I, Airoldi I
    Eur. J. Immunol., 2012;42(6):1547-52.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  28. MiR-10b Downregulates the Stress-Induced Cell Surface Molecule MICB, a Critical Ligand for Cancer Cell Recognition by Natural Killer Cells.
    Authors: Tsukerman P, Stern-Ginossar N, Gur C, Glasner A, Nachmani D, Bauman Y, Yamin R, Vitenshtein A, Stanietsky N, Bar-Mag T, Lankry D, Mandelboim O
    Cancer Res, 2012;72(21):5463-72.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow
  29. Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins.
    Authors: Brown A, Dobbie I, Alakoskela J, Davis I, Davis D
    Blood, 2012;120(18):3729-40.
    Species: Human
    Sample Type: Whole Cells
    Application: Bioassay
  30. Wiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activation.
    Eur J Immunol, 2012;42(8):2142-51.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  31. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.
    Authors: Glassner A, Eisenhardt M, Kramer B, Korner C, Coenen M, Sauerbruch T, Spengler U, Nattermann J
    Lab. Invest., 2012;92(7):967-77.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  32. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
    Authors: Nielsen N, Odum N, Urso B, Lanier LL, Spee P
    PLoS ONE, 2012;7(2):e31959.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  33. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.
    Authors: Heinemann A, Zhao F, Pechlivanis S, Eberle J, Steinle A, Diederichs S, Schadendorf D, Paschen A
    Cancer Res., 2012;72(2):460-71.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow
  34. 2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.
    Authors: Andresen L, Skovbakke SL, Persson G, Hagemann-Jensen M, Hansen KA, Jensen H, Skov S
    J. Immunol., 2012;188(4):1847-55.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  35. Analysis of Vdelta1 T cells in clinical grade melanoma-infiltrating lymphocytes.
    Authors: Donia M, Ellebaek E, Andersen M, Straten P, Svane I
    Oncoimmunology, 2012;1(8):1297-1304.
    Species: Human
    Sample Type: Whole Cells
    Application: Blocking
  36. NKG2A inhibits NKG2C effector functions of gammadelta T cells: implications in health and disease.
    Authors: Angelini DF, Zambello R, Galandrini R, Diamantini A, Placido R, Micucci F, Poccia F, Semenzato G, Borsellino G, Santoni A, Battistini L
    J. Leukoc. Biol., 2011;89(1):75-84.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  37. Potent anti-tumor killing activity of the multifunctional Treg cell line HOZOT against human tumors with diverse origins.
    Authors: Inoue T, Tashiro Y, Takeuchi M
    Int. J. Oncol., 2011;38(5):1299-306.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  38. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.
    Authors: Ardolino M, Zingoni A, Cerboni C, Cecere F, Soriani A, Iannitto ML, Santoni A
    Blood, 2011;117(18):4778-86.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow
  39. Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling.
    Authors: Qin H, Lee IF, Panagiotopoulos C, Wang X, Chu AD, Utz PJ, Priatel JJ, Tan R
    Diabetes, 2011;60(3):857-66.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  40. Analysis of HLDA9 mAbs on plasmacytoid dendritic cells.
    Authors: Cabezon R, Sintes J, Llinas L, Benitez-Ribas D
    Immunol. Lett., 2011;134(2):167-73.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow
  41. Cytotoxicity of activated natural killer cells against pediatric solid tumors.
    Authors: Cho D, Shook DR, Shimasaki N
    Clin. Cancer Res., 2010;16(15):3901-9.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  42. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
    Authors: Maniar A, Zhang X, Lin W, Gastman BR, Pauza CD, Strome SE, Chapoval AI
    Blood, 2010;116(10):1726-33.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  43. Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.
    Authors: Markel G, Seidman R, Besser MJ
    PLoS ONE, 2009;4(5):e5597.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  44. Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells.
    Authors: Cerboni C, Ardolino M, Santoni A, Zingoni A
    Blood, 2009;113(13):2955-64.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  45. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Authors: Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A
    Int. J. Cancer, 2009;124(7):1594-604.
    Species: Human
    Sample Type: Whole Cells
    Application: Blocking
  46. SHP-2 expression negatively regulates NK cell function.
    Authors: Purdy AK, Campbell KS
    J. Immunol., 2009;183(11):7234-43.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  47. Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine.
    Authors: Tang KF, He CX, Zeng GL, Wu J, Song GB, Shi YS, Zhang WG, Huang AL, Steinle A, Ren H
    Biochem. Biophys. Res. Commun., 2008;370(4):578-83.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  48. Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity.
    Authors: Kwong KY, Baskar S, Zhang H, Mackall CL, Rader C
    J. Mol. Biol., 2008;384(5):1143-56.
    Species: Human
    Sample Type: Peptide
    Application: Surface Plasmon Resonance
  49. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
    Authors: Dulphy N, Haas P, Busson M, Belhadj S, Peffault de Latour R, Robin M, Carmagnat M, Loiseau P, Tamouza R, Scieux C, Rabian C, Di Santo JP, Charron D, Janin A, Socie G, Toubert A
    J. Immunol., 2008;181(3):2227-37.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  50. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
    Authors: Verhoeven DH, de Hooge AS, Mooiman EC, Santos SJ, ten Dam MM, Gelderblom H, Melief CJ, Hogendoorn PC, Egeler RM, van Tol MJ, Schilham MW, Lankester AC
    Mol. Immunol., 2008;45(15):3917-25.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  51. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Authors: Zhang H, Snyder KM, Suhoski MM, Maus MV, Kapoor V, June CH, Mackall CL
    J. Immunol., 2007;179(7):4910-8.
    Species: Human
    Sample Type: Whole Cells
    Application: Functional Assay
  52. Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma.
    Authors: Shi J, Tricot GJ, Garg TK, Malaviarachchi PA, Szmania SM, Kellum RE, Storrie B, Mulder A, Shaughnessy JD, Barlogie B, van Rhee F
    Blood, 2007;111(3):1309-17.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  53. 4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells.
    Authors: Kim YJ, Han MK, Broxmeyer HE
    Blood, 2007;111(3):1378-86.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
  54. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL).
    Authors: Hanabuchi S, Watanabe N, Wang YH, Ito T, Shaw J, Cao W, Qin FX, Liu YJ
    Blood, 2006;107(9):3617-23.
    Species: Human
    Sample Type: Recombinant Protein
    Application: Neut
  55. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.
    Authors: Roda-Navarro P, Vales-Gomez M, Chisholm SE, Reyburn HT
    Proc. Natl. Acad. Sci. U.S.A., 2006;103(30):11258-63.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow
  56. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Authors: Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D
    J. Leukoc. Biol., 2005;78(2):359-71.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow
  57. BCR/ABL promotes dendritic cell-mediated natural killer cell activation.
    Authors: Terme M, Borg C, Guilhot F, Masurier C, Flament C, Wagner EF, Caillat-Zucman S, Bernheim A, Turhan AG, Caignard A, Zitvogel L
    Cancer Res., 2005;65(14):6409-17.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
Expand to show all Citations

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Isotype Controls
Description Application Cat# Citations Images  

Mouse IgG1 Isotype Control

Ctrl MAB002 150  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Mouse IgG1 Isotype Control

Ctrl MAB002R 1
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....
Reconstitution Buffers
Description Application Cat# Citations Images  

Reconstitution Buffer 1 (PBS)

RB01
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....
Secondary Antibodies
Description Application Cat# Citations Images  

Mouse IgG HRP-conjugated Antibody

WB HAF007 33  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Mouse F(ab)2 IgG (H+L) PE-conjugated Antibody

Flow F0102B 12  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Donkey Anti-Mouse IgG NorthernLights™ NL557-conjugate Antibody

Flow , IHC , ICC NL007 11
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Mouse IgG HRP-conjugated Antibody

WB HAF018 9  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Donkey Anti-Mouse IgG NorthernLights™ NL637-conjugated Antibody

Flow , IHC , ICC NL008 8
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Mouse F(ab)2 IgG (H+L) APC-conjugated Antibody

Flow F0101B 4  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Donkey Anti-Mouse IgG NorthernLights™ NL493-conjugated Antibody

Flow , IHC , ICC NL009 5
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Mouse IgG Antibody

WB AF007 4
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Donkey Anti-Mouse IgG Biotinylated Antibody

WB BAF018 1
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Goat Anti-Mouse IgG Biotinylated Antibody

WB BAF007 4
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Mouse F(ab)2 IgG (H+L) Fluorescein-conjugated Antibody

Flow F0103B 5  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Mouse/Rabbit IgG VisUCyte HRP Polymer Antibody

IHC VC002 1  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Mouse IgG VisUCyte HRP Polymer Antibody

IHC VC001  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Mouse F(ab)2 IgG (H+L) PerCP-conjugated Antibody

Flow F0114  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....
Average Rating: 5 (Based on 1 review)

Have you used Human NKG2D/CD314 Antibody?

Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

Read what people are saying who have used Human NKG2D/CD314 Antibody.

We have 1 review tested in 1 species: Human.
We have 1 review tested in 1 application: Immunohistochemistry.

Filter by Ratings
Excellent
(1)
All Ratings
Filter by Applications
IHC
(1)
All Applications
Filter by Species
Human
(1)
All Species

Images Ratings Applications Species Reviewed By Date Details
Excellent
 IHC Human Anonymous 04/13/2018
Show

Summary

Application Immunohistochemistry
Sample Tested Paraffined tumor tissue from HCC xenograft
Species Human

Please scroll the above reviews for more

Order Details

Contact Us to Order
reload

Feedback

Customer Information
Calculators

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Monoclonal
Antibody
Panels For
Screening

Learn More
Monoclonal Antibodies
R&D Systems Guarantee